Alpha Teknova

Alpha Teknova

TKNO
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

TKNO · Stock Price

USD 4.00-3.06 (-43.34%)
Market Cap: $201.6M

Historical price data

Overview

Alpha Teknova's mission is to accelerate scientific discovery and therapeutic production by providing mission-critical, high-quality reagents with exceptional consistency. The company has established itself as a trusted cGMP manufacturer, supporting the rapid growth of advanced therapeutic modalities like cell and gene therapies. Its strategy focuses on leveraging its configurable manufacturing platform to expand its standard catalog and develop custom solutions, thereby deepening its integration into client workflows. As a public small-cap company, Teknova aims to capitalize on the robust, long-term demand drivers within the life sciences sector.

Life SciencesLab Reagents

Technology Platform

A sophisticated, configurable manufacturing and formulation platform for liquid and powdered reagents, built on expertise in microbial fermentation, chemical synthesis, purification, and aseptic filling to ensure lot-to-lot consistency and cGMP compliance.

Opportunities

Alpha Teknova is poised to capitalize on powerful secular trends, including the rapid growth of biologics and advanced therapies (CGT, mRNA), which are reagent-intensive, and the biopharma industry's drive for supply chain resilience and outsourcing of non-core manufacturing.
Its cGMP-compliant platform and custom configuration capabilities allow it to capture greater value as client programs advance from research to commercial production.

Risk Factors

Key risks include customer concentration, intense competition from larger, well-capitalized conglomerates, vulnerability to supply chain disruptions and input cost inflation, and sensitivity to downturns in biotech funding which can reduce client R&D spending.
As a small-cap stock, it is also subject to significant market volatility.

Competitive Landscape

Teknova competes in a fragmented market against global giants (Thermo Fisher, Merck) and specialized peers (Fujifilm Irvine Scientific). It differentiates through focused agility, deep cGMP expertise for production workflows, and a highly configurable platform for custom solutions, positioning it as a strategic partner rather than a generic supplier.